Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
opioid antagonist
Pharma
Supernus-Indivior merger is about scale, business development
Supernus and Indivior have agreed to a merger, forming a new CNS-focused biopharma, which will generate an expected $2.2B in sales this year.
Kevin Dunleavy
Aug 3, 2026 11:20am
Indivior to discontinue Opvee marketing after NY settlement
Sep 30, 2025 1:27pm
Purdue Pharma snags nod for new overdose-reversal injection
Aug 9, 2024 9:35am
'The Top Line': Most influential people, plus the headlines
May 26, 2023 6:00am
'The Top Line': Part 2 of a series on Narcan
May 5, 2023 4:00am
'The Top Line': A series on Narcan, plus this week's headlines
Apr 28, 2023 6:00am
